spacer
home > epc
PUBLICATIONS

European Pharmaceutical Contractor

 

Published quarterly, European Pharmaceutical Contractor (EPC) covers the essential contract research issues between pharma companies and their CRO partners. The title, which is integrated within International Clinical Trials (ICT) magazine, offers a strategic view of the drug development industry – giving its pharma, biotech and CRO readership expert insight and analysis on the sponsor-service provider landscape.

EPC focuses on key trends, concerns and developments in contract research operations across the drug development spectrum, from preclinical to post-marketing. It explores the shifting collaborative needs and practical implications for sponsors and their contract partners, with the emphasis on building and managing effective collaborations.

Prompted by the synergies between outsourcing and trial operations, EPC joined forces with sister brand ICT in late-2015, in a move that brings added value to both brands. With EPC now an inserted edition within ICT, industry practitioners across these complementary subject areas now have unrivalled access to a wealth of shared views and analyses.

 

For further information please contact:

Advertising
Nick Matthews

Editorial
Thanh Thanh Lam

We're also on Twitter! Follow us @EPCmagazine

The latest digital edition of EPC can be viewed here
 

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.


epc
 
 
Featured in this issue
Marketplace & Business
Pricing and Market Access

People Skills


According to a-connect's Aunia Grogan and Claire Hempshall, it is vital to establish and maintain access to drugs in an evolving environment, which is characterised by tight budgets, shifting market trends and new therapy areas, among others.


Medical Writing
Medical Writing Metrics

Do You Measure Up?


There is a pressing need to measure the performance of service providers for evaluation purposes, states Trilogy Writing & Consulting’s Dr Julia Forjanic Klapproth, while emphasising that metrics for medical writing are not simple to establish.

  Electronic Solutions
Patient Communication Technology

Talk Technical


Dr Mark Hooper at Conversis Medical Translations observes how technology has an impact on nearly all areas in the pharma industry, and that patient adherence, communication, enrolment and retention can be improved as a result.

spacer



Published quarterly in
February, May,
August and November


 

Industry Events

all4pack

14-17 November 2016, Paris Nord Villepinte, France

In light of increasing integration along the entire production chain, the EMBALLAGE and MANUTENTION exhibitions have confirmed their complementary nature by becoming ALL4PACK Paris, the global marketplace for Packaging, Processing, Printing & Handling. This marks a strategic move in response to buyers’ expectations and reinforces the event’s key position for the EMEA region at an international level. With 6 months to go before ALL4PACK Paris opens, the new setup is attracting attention and registration numbers are rising.
More info >>

 
News and Press Releases

PPD Named Best Contract Research Organization

PPD today announced it has been named best contract research organization (CRO) in the Triangle Business Journal’s 2016 Life Sciences Awards.
More info >>

air transport logo

 

White Papers

Clinical Trials in Ukraine: Orange Paper Overview and 1st Half Year 2014

Synergy Research Group

The Orange Paper is an analytical report about the clinical trials market in Russia, published quarterly by the contract research organization Synergy Research Group. The first edition of Orange Paper was released in 2006, and at the moment 31 issues have already published. Now, thanks to Synergy Group Ukraine, obtaining information about the market of clinical trials in Ukraine has become possible. In Ukraine, during the period from 1996 to 2013, applicants had obtained 3,864 positive conclusions about the possibility of conducting clinical trials of drugs, both for domestic and foreign manufacturers, including conduct of multinational multi-center clinical trials (hereinafter – MMCTs)
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement